The foundation of “problem solving” is defining the issue, which is a frequently overlooked step. At the same time the client’s business situation and needs are made to bend and flex in order to fit the solutions being offered by the vendor.

Epiphany Insights has a different approach. We understand the importance of having clearly defined business objectives from all stakeholders point of view. Thus our engagements start with defining to the core business issue, both the identified and any latent needs, by taking the time to talk to all the stakeholders.

The situational assessment & needs analysis phase serves as the foundation for the partnership between the Epiphany team and our clients. During this phase, we will often uncover additional business needs as well as providing an opportunity to address and concerns or objections.

  • At Epiphany Insights, the “big” in big data is about what can be done with the data – not the size of it. The key to turning big possibilities into realities is making the data usable and accessible.

    All too often only a fraction of data and information available to companies are actually used in decision making. Epiphany Insights data management capabilities look to change this by helping organize and integrate your data so there is a single version of the truth.

    Once data has been collected and integrated into a usable format the next step is to determine who requires what information to advance the business’s goals. With the who and what identified it is a matter of developing and delivering regular reports or dash boards to those who need it most.

As the concept of ‘Big Data’ becomes more popular, so does the desire for analytics. As a company that is founded on the concept of evidence-based decision making, we are proponents of good analysis. This raises the question of what is good analytics.
The Epiphany Insights philosophy of good analytics can be summarized into four key points:

  • Be relevant: the analysis which is undertaken must be applicable to the business situations and needs.
  • Be timely: There is no use in great analysis that comes after opportunities have passed. A balance must be found between depth, insights and delivering results to meet the business time constraints.
  • Don’t over complicate it: In keeping with Occam’s Razor which essentially says the simplest answer is often correct, Epiphany Insights believes in not over complicating our analysis. Models which are not over complicated often gain greater acceptance. And stakeholder acceptance is more important than the data inputs and analytics. Without complete buy-in and implementation, it all becomes an academic exercise.
  • Be Transparent: In the same way we do not want to over complicate the analysis, transparency is paramount – black box analytics just do not work. If stakeholders are kept in the dark they are not going to be comfortable implementing the resulting recommendation.

With the analytical philosophy outline above Epiphany Insights analytical work covers a range of situations:

  • Market Assessment and Forecasting
    • Patient Based Models
  • Segmentation
    • Predictive Behavior Modeling
  • Targeting
    • Prescriber Profiling
    • Prescriber Link / KOL mapping
  • Promotional Response
    • Test & Control
    • Regression Based Models
Tracking and measuring performance are key steps in data generation and a foundation for evidence-based decision making.

Epiphany Insights works with our partners to define key metrics of success and design how they will be measured from the earliest stages of planning.

In measuring marketing performance Epiphany Insights employs various techniques that range from test vs. control through to more advanced regression based modeling.

In addition to working with your data, Epiphany Insights can provide access to two key sets of healthcare data:

  • Medical Claims data with over 150 million active profiles covering hospitals, clinics and physicians offices, updated daily.
  • Prescriber and KOL database with full profile and relationship mapping of all prescribers in the US.